Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
A common denominator among the multiple damage-inducing agents that ultimately lead to activation of NLRP3 has not yet been identified. Recently, production of reactive oxygen species (ROS) has been suggested to act as a common event upstream of the NLRP3 inflammasome machinery. Because de novo translation of NLRP3 is an essential step in the activation of NLRP3, we investigated the role of substances that inhibit either ROS production or its oxidative activity. Although we observe that NLRP3 inflammasome activation is unique among other known inflammasomes in its sensitivity to ROS inhibition, we have found that this phenomenon is attributable to the fact that NLRP3 strictly requires priming by a proinflammatory signal, a step that is blocked by ROS inhibitors. Although these data do not exclude a general role for ROS production in the process of NLRP3-triggered inflammation, they would put ROS upstream of NLRP3 induction, but not activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, these toxins mediate increased ROS production, which activates intrinsic apoptotic pathways and the NLRP3 inflammasome, thereby inflicting cytotoxicity in keratinocytes, neutrophils, and other tissue cells [14].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“Owing to the highly proinflammatory potential of bioactive IL-1b, its release is a tightly controlled process, in which caspase-1–mediated cleavage of pro–IL-1b is a rate-limiting step (1).”
BackgroundCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 1×
“To this effect, it has also been demonstrated that inhibitors of mitochondrial ROS production (17) and the knocking down of mitochondrial respiration by targeting the expression of voltage-dependent anion channels (18) downmodulate NLRP3-mediated inflammasome activation.”
BackgroundBauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959 · cited 4×
“Macrophages stably overexpressing NLRP3 were obtained through lentiviral transduction, as explained earlier (10).”
BackgroundMethodSelf-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Self-citationAIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Cited by
Items 101–200 of 676
Devi, T. S., Lee, I., Hüttemann, M., Kumar, A., Nantwi, K. D., & Singh, L. P. (2012) · Experimental Diabetes Research · doi:10.1155/2012/438238 · Cited by 198
Ding, T., Wang, S., Zhang, X., Zai, W., Fan, J., Chen, W., Bian, Q., Luan, J., Shen, Y., Zhang, Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.01.026 · Cited by 198
Of inflammasomes and pathogens – sensing of microbes by the inflammasome
Bauernfeind, F., & Hornung, V. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201771 · Cited by 195
“Hereby, oligomerization of the inflammasome sensors NLRP1, NLRP3, NLRP6 or AIM2 (HIN200 protein family) allows interaction of the respective N-terminal PYD with the PYD of the protein ASC (Apoptosis associated speck-like containing a CARD domain) (Bauernfeind et al, 2011a; Elinav et al, 2011).”
InfluentialSelf-citationRoles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Qiu, Y.-Y., & Tang, L.-Q. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.004 · Cited by 195
Lung inflammation caused by inhaled toxicants: A review
Wong, J., Magun, B., & Wood, L. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s106009 · Cited by 193
“Different mechanisms have been proposed for the activation of the inflammasome, including potassium efflux and the generation of reactive oxygen species, but both hypotheses have been challenged.(40,41) Other”
BackgroundKrishnan, S. M., Dowling, J. K., Ling, Y. H., Diep, H., Chan, C. T., Ferens, D., Kett, M. M., Pinar, A., Samuel, C. S., Vinh, A., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13230 · Cited by 192
“Stimuli known to lead to inflammasome priming include toll-like receptor ligands such as LPS, cytokines such as TNF and reactive oxygen species (Kahlenberg et al., 2005; Bauernfeind et al., 2009; 2011).”
BackgroundKey role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF
Takeshima, T., Pop, L. M., Laine, A., Iyengar, P., Vitetta, E. S., & Hannan, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613187113 · Cited by 191
“To determine whether the observed antitumor effect of RT-Ns was ROS-mediated, we used the NADPH oxidase inhibitor diphenyleneiodonium (DPI) to inhibit ROS production (20, 21).”
MethodThe NLRP3–inflammasome as a sensor of organelle dysfunction
Seoane, P. I., Lee, B., Hoyle, C., Yu, S., Lopez-Castejon, G., Lowe, M., & Brough, D. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202006194 · Cited by 190
“ROS production may also be involved in NLRP3 priming (Bauernfeind et al., 2011).”
BackgroundMitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Hu, D., Sheeja Prabhakaran, H., Zhang, Y.-Y., Luo, G., He, W., & Liou, Y.-C. (2024) · Critical Care · doi:10.1186/s13054-024-05069-w · Cited by 189
Mitochondrial quality control in pulmonary fibrosis
Larson-Casey, J. L., He, C., & Carter, A. B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101426 · Cited by 189
Nuclear Factor E2-related Factor-2 (Nrf2) Is Required for NLRP3 and AIM2 Inflammasome Activation
Zhao, C., Gillette, D. D., Li, X., Zhang, Z., & Wen, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563114 · Cited by 185
“ROS inhibition has been shown to block the priming or activation of the NLRP3 inflammasome (44, 46).”
BackgroundThe interplay between autophagy and ROS in tumorigenesis
Kongara, S., & Karantza, V. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00171 · Cited by 184
“…in Oncology | Molecular and Cellular Oncology November 2012 | Volume 2 | Article 171 | 6 “fonc-02-00171” — 2012/11/19 — 21:33 — page 7 — #7 priming step (Bauernfeind et al., 2011), since antioxidants attenuate IL-1β maturation in response to uric acid crystals (Petrilli et al., 2007; Dostert…”
BackgroundFranchi, L., Eigenbrod, T., Muñoz-Planillo, R., Ozkurede, U., Kim, Y.-G., Chakrabarti, A., Gale, M., Silverman, R. H., Colonna, M., Akira, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400582 · Cited by 183
“Consistent with recent studies (12, 24), Nlrp3 activation induced by ATP was unaffected by NAC.”
ResultSelf-citationSchroder, K., Sagulenko, V., Zamoshnikova, A., Richards, A. A., Cridland, J. A., Irvine, K. M., Stacey, K. J., & Sweet, M. J. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.020 · Cited by 181
“NLRP3 activation by ATP and other agonists is dependent on reactive oxygen species (ROS), although the precise role of ROS is controversial (Bauernfeind et al. 2011; Tschopp and Schroder 2010).”
BackgroundCell biology of inflammasome activation
Pandey, A., Shen, C., Feng, S., & Man, S. M. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.06.010 · Cited by 181
Updated insights into the molecular networks for NLRP3 inflammasome activation
Paik, S., Kim, J. K., Shin, H. J., Park, E.-J., Kim, I. S., & Jo, E.-K. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01284-9 · Cited by 180
“Additionally, ROS were found to be required for the priming, but not the assembly, step of the NLRP3 in fl ammasome pathway [100].”
Inflammasomes and Metabolic Disease
Henao-Mejia, J., Elinav, E., Thaiss, C. A., & Flavell, R. A. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170324 · Cited by 134
Metabolic reprogramming consequences of sepsis: adaptations and contradictions
Liu, J., Zhou, G., Wang, X., & Liu, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04490-0 · Cited by 179
“ROS also has been reported involved in LPS-induced IL-1β mRNA production [55]; both metformin and rotenone influence IL-1β production by affecting ROS production of mitochondrial complex I [56].”
BackgroundRecent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Zhou, K., Shi, L., Wang, Y., Chen, S., & Zhang, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/9238290 · Cited by 178
“Some studies implicate that mitochondrial ROS mediates the upregulation of NLRP3 and pro-IL-1 𝛽 transcription rather than the NLRP3 inflammasome activation [26].”
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Zheng, Q., Ren, Y., Reinach, P. S., Xiao, B., Lu, H., Zhu, Y., Qu, J., & Chen, W. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.02.013 · Cited by 174
Lighting the fires within: the cell biology of autoinflammatory diseases
Park, H., Bourla, A. B., Kastner, D. L., Colbert, R. A., & Siegel, R. M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3261 · Cited by 174
Hydrogen Peroxide: A Potential Wound Therapeutic Target
Zhu, G., Wang, Q., Lu, S., & Niu, Y. (2017) · Medical Principles and Practice · doi:10.1159/000475501 · Cited by 172
Zhang, H., Chen, X., Zong, B., Yuan, H., Wang, Z., Wei, Y., Wang, X., Liu, G., Zhang, J., Li, S., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13743 · Cited by 171
Inflammasomes in Intestinal Inflammation and Cancer
Chen, G. Y., & Núñez, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.002 · Cited by 150
Self-citationHaslund‐Vinding, J., McBean, G., Jaquet, V, & Vilhardt, F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13425 · Cited by 169
“The exact role of ROS in the signalling cascade leading to inflammasome activation is unclear (Bauernfeind et al., 2011), although the recent identification of specific ROS targets is an important step forward in this respect (Zhou et al.”
BackgroundHsu, C. G., Chávez, C. L., Zhang, C., Sowden, M., Yan, C., & Berk, B. C. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00966-5 · Cited by 168
Stringer, J. M., Alesi, L. R., Winship, A., & Hutt, K. J. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad005 · Cited by 169
The inflammasome in lung diseases
dos Santos, G., Kutuzov, M. A., & Ridge, K. M. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00225.2012 · Cited by 167
“For instance, NLRP3 is expressed at limited levels in macrophages and is highly inducible in response to proinflammatory stimuli such as LPS, cytokines, or ROS (5).”
BackgroundInfluentialInflammasomes link vascular disease with neuroinflammation and brain disorders
Lénárt, N., Brough, D., & Dénes, Á. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16662043 · Cited by 166
“ROS are thought to be key mediators of NLRP3 activation, as blocking NOX-dependent ROS production, or scavenging by N-acetylcysteine (NAC), in macrophages inhibits NLRP3 inflammasome activation by interfering the priming step required for the induction of NLRP3 expression.(196) It has also been shown that NLRP3 activa…”
BackgroundAutophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin, L., Zhang, M.-X., Zhang, L., Zhang, D., Li, C., & Li, Y.-L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809955 · Cited by 164
“The activation of caspase depends on the inflammasome, and oxidative stress is an initial signal that induces inflammasome activation and influences the priming phase of inflammasomes (Bauernfeind et al., 2011; Swanson et al., 2019).”
BackgroundProteolytic Processing of Nlrp1b Is Required for Inflammasome Activity
Frew, B. C., Joag, V. R., & Mogridge, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002659 · Cited by 162
Zhu, Y., Zhu, C., Yang, H., Deng, J., & Fan, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104746 · Cited by 162
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 162
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Di Virgilio, F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 161
“It is possible that ROS act at multiple levels in NLRP3 inflammasome activation, i.e., at the level of NLRP3 gene expression and as final triggers of inflammasome activation (Bauernfeind et al., 2011).”
BackgroundDe Santa, F., Vitiello, L., Torcinaro, A., & Ferraro, E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7420 · Cited by 151
“On the other hand, ROS also activate the inflammasome, and many redox-sensitive proteins are crucial in the signaling triggered by inflammatory mediators (14, 65, 289, 331); indeed, NOX inhibition favors M2 polarization (51).”
Guo, H., Gao, J., Taxman, D. J., Ting, J. P. Y., & Su, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566620 · Cited by 159
“NLRP3 Inflammasome Activation in Responses to HIV-1 Is Dependent on ROS Production and Cathepsin B—The induction of ROS is often critical for inflammasome activation (44, 45).”
BackgroundSpectrum and Mechanisms of Inflammasome Activation by Chitosan
Bueter, C. L., Lee, C. K., Wang, J. P., Ostroff, G. R., Specht, C. A., & Levitz, S. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301695 · Cited by 158
“ROS may not only be involved in the NLRP3 activation, but may also be important for the priming step, the upregulation of pro–IL-1b and NLRP3 (48).”
BackgroundReactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye
Zheng, Q., Ren, Y., Reinach, P. S., She, Y., Xiao, B., Hua, S., Qu, J., & Chen, W. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.05.001 · Cited by 158
“Recently, increases in ROS generation were found to be a key factor to activate NLRP3 (nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3) inflammasomes (Bauernfeind et al., 2011; Gross et al., 2011).”
BackgroundHydrogen peroxide release by bacteria suppresses inflammasome-dependent innate immunity
Erttmann, S. F., & Gekara, N. O. (2019) · Nature Communications · doi:10.1038/s41467-019-11169-x · Cited by 156
Biochemical regulation of the inflammasome
Dowling, J. K., & O’Neill, L. A. J. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.694844 · Cited by 135
“Firstly, the binding of MDP to the LRR of NLRP1 induced a conformational change, which in turn allowed subsequent binding of nucleotide triphosphates (NTPs) and self oligomerization via the NACHT domain.”
BackgroundInfluentialLuo, Y., Jiang, L., Kang, K., Fei, D., Meng, X., Nan, C., Pan, S., Zhao, M., & Zhao, M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.017 · Cited by 154
“A recent study demonstrated that increased ROS promoted NLRP3 expression at the transcriptional level, but not NLRP3 activation [35].”
BackgroundMechanisms of NLRP3 priming in inflammaging and age related diseases
Gritsenko, A., Green, J., Brough, D., & López‐Castejón, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.08.003 · Cited by 153
“In this setting, ROS inhibition dose-dependently inhibits the expression of NLRP3 and also prevents inflammasome activation when ROS is inhibited prior to LPS priming [65].”
BackgroundInnate Immunity and Biomaterials at the Nexus: Friends or Foes
Christo, S. N., Diener, K. R., Bachhuka, A., Vasilev, K., & Hayball, J. D. (2015) · BioMed Research International · doi:10.1155/2015/342304 · Cited by 134
“Contradicting reports suggest that ROS solely acts to upregulate NLRP3 and pro-IL-1β expression in an NFκB-dependent manner [235], and other studies demonstrated how ROS can be sensed by a complex ofThioredoxin (TXN) and TXN interacting protein (TXNIP) which binds to NLPR in conditions of oxidative stress [236].”
BackgroundNLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 152
Gasdermin D pore-forming activity is redox-sensitive
Devant, P., Boršić, E., Ngwa, E. M., Xiao, H., Chouchani, E. T., Thiagarajah, J. R., Hafner‐Bratkovič, I., Evavold, C. L., & Kagan, J. C. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112008 · Cited by 152
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Seo, Y. S., & Shah, V. H. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.4.337 · Cited by 141
“Previous studies suggested that LPS significantly induces the mRNA expression of inflammasome components, including NLRP3, ASC, and caspase-1, and pro-IL-1β and pro-IL-18 via NFκB activation.(101,102) Serum levels of IL-1β were increased in alcoholic lever disease.”
BackgroundZhang, X., Wang, Z., Zheng, Y., Yu, Q., Zeng, M., Bai, L., Yang, L., Guo, M., Jiang, X., & Gan, J. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5238 · Cited by 150
Habtemariam, S. (2023) · Biomedicines · doi:10.3390/biomedicines11020545 · Cited by 148
Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1βProduction
Tőzsér, J., & Benkő, S. (2016) · Mediators of Inflammation · doi:10.1155/2016/5460302 · Cited by 128
“Moreover, ROS influences signal transduction pathways such as NFκB; thus, besides NLRP3 inflammasome activation, it is also thought to play a role in the “priming” step [36].”
BackgroundTLR activation regulates damage‐associated molecular pattern isoforms released during pyroptosis
Nyström, S., Antoine, D. J., Lundbäck, P., Lock, J. G., Niță, A. F., Högstrand, K., Grandien, A., Erlandsson-Harris, H., Andersson, U., & Applequist, S. E. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.328 · Cited by 145
“NLRC4 gene expression is independent of priming (Bauernfeind et al , 2011).”
Pyroptosis-Induced Inflammation and Tissue Damage
Wei, Y., Yang, L., Pandeya, A., Cui, J., Zhang, Y., & Li, Z. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167301 · Cited by 142
Cyclooxygenase‐2 Regulates NLRP3 Inflammasome‐Derived IL‐1β Production
Hua, K., Chou, J., Ka, S., Tasi, Y., Chen, A., Wu, S., Chiu, H., Wong, W., Wang, Y., Tsai, C., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24815 · Cited by 130
“Effect of COX-2 on ROS generation and mitochondrial homeostasis ROS play an important role in NLRP3 inflammasome activation (Tschopp and Schroder, 2010; Bauernfeind et al., 2011).”
BackgroundThe Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation
Zhou, Y., Tong, Z., Jiang, S., Zheng, W., Zhao, J., & Zhou, X. (2020) · Cells · doi:10.3390/cells9051219 · Cited by 140
“However, later studies demonstrated that ROS only control NLRP3 inflammasome activation in the priming step, but not in the activation step [30].”
BackgroundInfluentialCarta, S., Penco, F., Lavieri, R., Martini, A., Dinarello, C. A., Gattorno, M., & Rubartelli, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424741112 · Cited by 126
Perret, M., Badiou, C., Lina, G., Burbaud, S., Benito, Y., Bes, M., Cottin, V., Couzon, F., Juruj, C., Dauwalder, O., et al. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01772.x · Cited by 118
“To induce proIL-1b and prime the NLRP3 inflammasome (Bauernfeind et al., 2011), we treated macrophages with heat-killed S.”
An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology
Ratsimandresy, R. A., Dorfleutner, A., & Stehlik, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00440 · Cited by 109
Ambiguities in NLRP3 inflammasome regulation: Is there a role for mitochondria?
Lawlor, K. E., & Vince, J. E. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.08.014 · Cited by 131
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
Zhang, Y., Zhao, Y., Zhang, J., & Yang, G. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03121-z · Cited by 131
Activation of the Nlrp1b Inflammasome by Reduction of Cytosolic ATP
Liao, K., & Mogridge, J. (2012) · Infection and Immunity · doi:10.1128/iai.01003-12 · Cited by 130
“Recently, however, the requirement for ROS has been suggested to be at the priming stage—the expression of NLRP3—rather than the activation stage (21).”
BackgroundRegulation of the NLRP3 inflammasome by autophagy and mitophagy
Gupta, S., Cassel, S. L., Sutterwala, F. S., & Dagvadorj, J. (2024) · Immunological Reviews · doi:10.1111/imr.13410 · Cited by 132
“18,19 However, this transcriptional upregulation and new protein translation alone are now known to be dispensable for NLRP3 inflammasome activation.”
Kim, S. (2022) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2022.29.3.140 · Cited by 128
“Recent studies demonstrated that macrophages with overexpression of NLRP3 using a retroviral vector markedly induced NLRP3 inflammasome activation without priming [13,19], suggesting that priming for NFκB-dependent transcription upregulation of NLRP3 is a crucial step for induction of NLRP3 inflammasome activation.”
BackgroundNLRP3 inflammasome: The rising star in cardiovascular diseases
Zheng, Y., Li, X., Dong, N., & Li, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.927061 · Cited by 127
“provided a new perspective of ROS function, showing that ROS inhibitors also blocked the priming signal of NLRP3 activation (41).”
Traba, J., Geiger, S. S., Kwarteng-Siaw, M., Han, K., Ra, O. H., Siegel, R. M., Gius, D., & Sack, M. N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791715 · Cited by 119
“Interestingly, mitochondrial reactive oxygen species (ROS) have been found to play a role in inflammasome priming (8, 9).”
BackgroundSolini, A., Menini, S., Rossi, C., Ricci, C., Santini, E., Blasetti Fantauzzi, C., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 107
“AGEs, advanced glycation end-products; ALEs, advanced lipoxidation end-products; ASC, apoptosisassociated speck-like protein containing a caspase recruitment domain; BP, blood pressure; CARD, caspase recruitment domain; CKD, chronic kidney disease; CML, N -(carboxymethyl)lysine; eATP, extracellular ATP; ECM, extracell…”
BackgroundInfluentialInflammatory Monocytes Drive Influenza A Virus–Mediated Lung Injury in Juvenile Mice
Coates, B. M., Staricha, K. L., Koch, C. M., Cheng, Y., Shumaker, D. K., Budinger, G. R. S., Perlman, H., Misharin, A. V., & Ridge, K. M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701543 · Cited by 123
“Pro–IL-18 is constitutively expressed, but a priming signal is required for the production of pro–IL-1b (23).”
BackgroundIKKα negatively regulates ASC-dependent inflammasome activation
Martin, B. N., Wang, C., Willette‐Brown, J., Herjan, T., Gulen, M. F., Zhou, H., Bulek, K., Franchi, L., Sato, T., Alnemri, E. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5977 · Cited by 122
Self-citationWu, G., Zhu, Q., Zeng, J., Gu, X., Miao, Y., Xu, W., Lv, T., & Song, Y. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.26 · Cited by 107
“It has been shown that numbers of pathogen associated molecular patterns (PAMPs) were able to promote NLRP3 inflammasome activation (8,9).”
BackgroundCellular Senescence and Regulated Cell Death of Tubular Epithelial Cells in Diabetic Kidney Disease
Shen, S., Ji, C., & Wei, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.924299 · Cited by 122
Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome Activation
Schmidt, R. L., & Lenz, L. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045186 · Cited by 105
“These data confirm that inhibition of ROS production after TLR stimulation does not block NLRP3 expression [43], and suggest that ROS selectively stimulate NLRP3 inflammasome activity leading to IL-1b secretion.”
BackgroundInfluentialAdvances in Nod-like receptors (NLR) biology
Barbé, F., Douglas, T., & Saleh, M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.001 · Cited by 120
“The role of reactive oxygen species (ROS) in NLRP3 priming is a matter of debate [129,130].”
BackgroundRedox control of NLRP3 inflammasome activation in health and disease
Rubartelli, A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512265 · Cited by 112
“[27] reported that NLRP3, like IL-1 , strictly requires priming by a proinflammatory signal (a step that is blocked by ROS inhibitors) and proposed that ROS production is necessary for NLRP3 induction but not activation.”
BackgroundMultiple inflammasome complexes are activated in autistic spectrum disorders
Saresella, M., Piancone, F., Marventano, I., Zoppis, M., Hernis, A., Zanette, M., Trabattoni, D., Chiappedi, M. A., Ghezzo, A., Canevini, M. P., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.009 · Cited by 117
Biochemistry of proinflammatory macrophage activation
Nonnenmacher, Y., & Hiller, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2784-1 · Cited by 118
“1 3 which have been reported to affect inflammasome priming [102].”
BackgroundŚlusarczyk, J., Trojan, E., Głombik, K., Piotrowska, A., Budziszewska, B., Kubera, M., Popiołek-Barczyk, K., Lasoń, W., Mika, J., & Basta-Kaim, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071965 · Cited by 112
“On the other hand, a recent study suggested that ROS are only necessary for priming the inflammasome [67]; therefore, further detailed studies of these mechanisms are required.”
BackgroundInhibitory effect of PPARγ on NLRP3 inflammasome activation
Yang, C.-C., Wu, C., Lin, T., Cheng, Y.-N., Chang, C.-S., Lee, K., Tsai, P.-J., & Tsai, Y.-S. (2020) · Theranostics · doi:10.7150/thno.46873 · Cited by 117
“Therefore, we modified the rosiglitazone treatment protocol to two stages, which have been used previously to dissect the effect of a variant of chemicals on inflammasome activation [52, 53].”
MethodGopinath, P. M., Twayana, K. S., Ravanan, P., Thomas, J., Mukherjee, A., Jenkins, D., & Chandrasekaran, N. (2021) · Particle and Fibre Toxicology · doi:10.1186/s12989-021-00428-9 · Cited by 117
Kodali, M., Madhu, L. N., Reger, R. L., Milutinovic, B., Upadhya, R., Gonzalez, J. J., Attaluri, S., Shuai, B., Gitai, D. L. G., Rao, S., et al. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.11.014 · Cited by 105
“NLRP3 inflammasome activation after TBI is triggered through multiple danger-associated molecular patterns, including the increased concentration of reactive oxygen species (Bauernfeind et al., 2011) and the high mobility group box 1 (Frank et al.”
BackgroundPrinciples of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Autophagy Mediates Interleukin-1β Secretion in Human Neutrophils
Iula, L., Keitelman, I. A., Sabbione, F., Fuentes, F., Guzmán, M., Galletti, J. G., Gerber, P. P., Ostrowski, M., Geffner, J. R., Jancic, C. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00269 · Cited by 116
Liu, Y., Sun, Y., Kang, J., He, Z.-Q., Liu, Q., Wu, J., Li, D., Wang, X., Tao, Z., Guan, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.818625 · Cited by 114
Teixeira-Santos, L., Albino‐Teixeira, A., & Pinho, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105280 · Cited by 114
Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
Yabal, M., Calleja, D. J., Simpson, D. S., & Lawlor, K. E. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-124r · Cited by 109
Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome
Wynosky-Dolfi, M. A., Snyder, A. G., Philip, N. H., Doonan, P. J., Poffenberger, M. C., Avizonis, D., Zwack, E. E., Riblett, A. M., Hu, B., Strowig, T., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130627 · Cited by 103
“ROS plays a role both in the activation of the inflammasome complex itself, as well as in up-regulation of NLRP3 inflammasome components (Bauernfeind et al., 2011).”
BackgroundBettencourt, I. A., & Powell, J. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601318 · Cited by 103
“In addition, reactive oxygen species (ROS) are associated with priming the NLRP3 inflammasome (26).”
BackgroundPark, B., Jo, K., Lee, T. G., Hyun, S., Kim, J. S., & Kim, C. (2019) · Nutrients · doi:10.3390/nu11112792 · Cited by 110
“Many studies showed that ROS generation is an essential factor activating NLRP3 (NACHT, LRR, and PYD domain-containing protein 3, nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3) inflammasome [5].”
BackgroundPlastic particles in medicine: A systematic review of exposure and effects to human health
Gopinath, P. M., Parvathi, V. D., Nagarajan, Y., Kumar, S. M., Athulya, P. A., Mukherjee, A., & Chandrasekaran, N. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.135227 · Cited by 106
Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process
Salminen, A., Hyttinen, J. M. T., Kauppinen, A., & Kaarniranta, K. (2012) · International Journal of Cell Biology · doi:10.1155/2012/849541 · Cited by 87
“[180] demonstrated that the NF-κB-provoked induction of NLRP3 expression, an inhibitory binding partner of Beclin 1 (Section 2.”
BackgroundChen, S., Wang, Y., Pan, Y., Liu, Y., Zheng, S., Ding, K., Mu, K., Yuan, Y., Li, Z., Song, H., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015513 · Cited by 105
Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas
Tarassishin, L., Casper, D., & Lee, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103432 · Cited by 96
“In macrophages, baseline NLRP3 protein expression is minimal and upregulation of NLRP3 is the (possibly only) critical step involved in inflammasome activation [43,74].”
BackgroundOzkurede, U., & Franchi, L. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04535.x · Cited by 105
Self-citationLiao, P., Chao, L. K., Chou, J., Dong, W.-C., Lin, C.-N., Lin, C.-Y., Chen, A., Ka, S., Ho, C., & Hua, K. (2012) · Inflammation Research · doi:10.1007/s00011-012-0555-2 · Cited by 104
“NLRP3 protein is essential for NLRP3 inflammasome activation, but is not expressed in resting macrophages [25, 26].”
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
Clayton, S. A., MacDonald, L., Kurowska‐Stolarska, M., & Clark, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673916 · Cited by 103
The inflammasome: in memory of Dr. Jurg Tschopp
Dagenais, M., Skeldon, A. M., & Saleh, M. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.159 · Cited by 105
The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
Jiang, D., Chen, S., Sun, R., Zhang, X., & Wang, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.034 · Cited by 102
Lee, J., & Song, C. (2021) · Antioxidants · doi:10.3390/antiox10060872 · Cited by 98
“NLRP3 activators also induce production of ROS via the NLRP3 inflammasome [82].”
BackgroundIs the inflammasome a potential therapeutic target in renal disease?
Turner, C. M., Arulkumaran, N., Singer, M., Unwin, R. J., & Tam, F. W. K. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-21 · Cited by 96
“The cell surface P2X7 receptor (P2X7R) facilitates assembly of the NLRP3 inflammasome [4-6].”
BackgroundXu, Y., Li, H., Chen, W., Yao, X., Xing, Y., Wang, X., Zhong, J., & Meng, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077955 · Cited by 96
“investigation showed that ROS inhibitors interfered with the transcription of IL-1b and NLRP3, but not affected activation of caspase-1 in mouse cells [40].”
BackgroundResultInfluentialAbais, J. M., Xia, M., Li, G., Gehr, T. W. B., Boini, K. M., & Li, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.009 · Cited by 93
“This concept, however, has been challenged, with evidence demonstrating that ROS inhibition prevents the priming, but not activation, of inflammasomes [66].”
Chen, Y., Le, T. H., Du, Q., Zhao, Z., Liu, Y., Zou, J., Hua, W., Liu, C., & Zhu, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.021 · Cited by 92
Metadata
- Authors
- Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., & Hornung, V.
- Affiliations
- University of Bonn (DE)
- University of Michigan (US)
- Corresponding author
- Bauernfeind, Franz
- Bartok, Eva
- Rieger, Anna
- Hornung, Veit
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07
- Volume
- 187
- Issue
- 2
- Pages
- 613-617
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3131480
- OpenAlex
- W1756750202
- Cited by
- 617
- References
- 25
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 41 · 2023: 32 · 2022: 43 · 2021: 32 · 2020: 48 · 2019: 36 · 2018: 41 · 2017: 26 · 2016: 41 · 2015: 50 · 2014: 46 · 2013: 70 · 2012: 45
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Takeda Oncology
- National Institute of Allergy and Infectious Diseases (R01AI063331)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091191)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- NLRP3 inflammasome, reactive oxygen species, inflammasome priming, inflammasome activation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, NADPH Oxidase 2, Animals, Biphenyl Compounds, Carrier Proteins, Cells, Cultured, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Mutant Strains, Onium Compounds, Signal Transduction, Down-Regulation, Reactive Oxygen Species, NADPH Oxidases, STAT1 Transcription Factor, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.